Skip to main content

ABOUT THE IBC

 

 

 

 

Program: The Institutional Biosafety Committee (IBC) plays a crucial role in ensuring the safe conduct of research involving biohazardous materials, including genetically modified organisms (GMOs), recombinant DNA (rDNA), pathogens, and other potentially dangerous biological agents. 

The federal responsibilities of an IBC primarily originate from the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. The NIH guidelines provide guidance for safe research practices in the United States and they are part of the institutional and federal oversight. 

Federally Responsibilities 

  1. Oversight of Research Involving Recombinant or Synthetic Nucleic Acids
  2. Review and Approval of Research Protocols
  3. Biosafety Levels and Containment Facilities
  4. Reporting to Federal Agencies
  5. Risk Assessment and Public Health Protection
  6. Education and Training

  Federal Regulation that the IBC Follows

 

Appointment of Members

The President of the institution delegates the Institutional Official (IO), who is the Vice-President for Research (VPR) the authority to appoint the members of the IBC committee, including the Chair. The IBC committee consists of research personnel, faculty, and members of the community who have the appropriate experience and expertise regarding the use of recombinant or synthetic DNA and the handling of biohazardous materials, agents, and toxins  

 Committee Composition

  • Chair of the IBC: Expertise in recombinant or synthetic nucleic acid molecules technology and expertise in select agents and toxins, The Chair oversees the IBC and ensures effective functioning of the committee.
  • Biosafety Officer (BSO): Provides expertise on biosafety practices, risk assessments, and compliance with safety regulations.
  • Researchers/Scientists: At least two members with expertise in creating and using recombinant or synthetic nucleic acid molecules.
  • Community Members: At least two non-affiliate members that represent the interest of the surrounding community concerning health and protection of the environment (e.g., officials of state or local public health or environmental protection agencies, members of other local governmental bodies, or persons active in medical, occupational health, or environmental concerns in the community).
  • Expert Members: Members with specialized knowledge in fields relevant to biosafety and research, such as microbiology, virology, molecular biology, animal research, or public health.

 IBC Member Responsibilities

  • Ensure that each IBC submission is reviewed with the highest standard of care according to the federal, state, local and institutional policies and guidelines.

 

 institutional biosafety committee (IBC) 2026

 Meetings are scheduled for every 4th Friday of each month. Dates may be subject to change. 

 Submission DEADLINE is the 1st Friday of each month by 5:00 pm (Mountain time).

 Documents must be submitted on eProtocol and received by the deadline to be considered for review. 

Submission DEADLINE on eProtocol * IBC Meeting **
January 9, 2026 January 23, 2026
February 6, 2026 February 27, 2026
March 6, 2026 March 27, 2026
April 3, 2026 April 24, 2026
May 1, 2026 May 22, 2026
June 5, 2026 June 26, 2026
July 3, 2026 July 24, 2026
August 7, 2026 August 28, 2026
September 4, 2026 September 25, 2026
October 2, 2026 October 23, 2026
November 6, 2026 November TBD, 2026
December 4, 2026 December TBD, 2026

  * Subject to change
** 10am-12N, Mountain Time, Virtual, Subject to change

Contact & Location

Kelly Hall, 4th floor
2101 Sun Bowl Drive
500 W. University Ave.
El Paso, TX 79968

  Main: 915-747-6056
  ibc@utep.edu